LAKE ZURICH, IL, USA I March 27, 2025 I Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilars Conexxence® ...
Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion ...
The system separates whole blood into concentrated cellular components and high quality plasma that can be processed as Source Plasma. The Aurora™ system takes Fenwal reliability and adds ...
Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion ...
This marks our sixth FDA biosimilar approval, expanding our portfolio to provide more affordable therapies to patients in the U.S.," said Dr. Sang Jin Pak, President Fresenius Kabi Biopharma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback